<DOC>
	<DOCNO>NCT02278952</DOCNO>
	<brief_summary>This non-interventional cohort study ass novel assay detect excessive insufficient immunosuppression drug tacrolimus lung transplant recipient . The assay measure mean residual expression ( MRE ) gene downstream NFAT , transcription factor regulate tacrolimus . The investigator assess whether MRE level identify subject risk rejection ( insufficient immunosuppression ) infection ( excessive immunosuppression ) .</brief_summary>
	<brief_title>Tacrolimus Adjustment NFAT-related Gene Expression Lung Allograft Recipients .</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Inclusion criterion : The study include lung allograft recipient within 2 month transplantation UCSF . Exclusion criterion : Subjects exclude ( ) unable provide consent ( b ) treating clinician anticipate subject start tacrolimus . Recruitment enrollment study target equally woman minority study exclude gender racial/ethnic group . This study involve vulnerable population .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>